Share Article

Webinar: Prostate Cancer Overview and Treatment Options

Dr. Paul Yonover and Dr. Par Mehta
UroPartners Cancer Treatment Center
Glenview, Illinois

Request More Information

Dr. Yonover and Metha

About 1 in 9 men will be diagnosed with prostate cancer and it is estimated that about 191,930 new cases will be diagnosed annually in the U.S. alone.1 Urologist Dr. Paul M. Yonover and radiation oncologist Dr. Par Mehta discuss prostate cancer and treatment options, including radiation with SpaceOAR Hydrogel.

  1. Key Statistics for Prostate Cancer. American Cancer Society. https://www.cancer.org/cancer/prostate-cancer/about/key-statistics.html. Accessed February 17, 2020.

SpaceOAR Hydrogel is intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of SpaceOAR Hydrogel to reduce the radiation dose delivered to the anterior rectum.

As with any medical treatment, there are some risks involved with the use of SpaceOAR Hydrogel. Potential complications associated with SpaceOAR Hydrogel include, but are not limited to: pain associated with SpaceOAR Hydrogel injection; pain or discomfort associated with SpaceOAR Hydrogel; needle penetration of the bladder, prostate, rectal wall, rectum or urethra; injection of SpaceOAR Hydrogel into the bladder, prostate, rectal wall, rectum or urethra; local inflammatory reactions; infection; injection of air, fluid or SpaceOAR Hydrogel intravascularly; urinary retention; rectal mucosal damage, ulcers, necrosis; bleeding; and rectal urgency. Please talk to your doctor about the risks and benefits associated with SpaceOAR Hydrogel.

Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.

All images are the property of Boston Scientific. URO-925102-AA JAN 2021